|
Volume 272, Number 6,
Issue of February 7, 1997
pp. 3216-3222
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.
Dexamethasone Induces Posttranslational Degradation of GLUT2 and
Inhibition of Insulin Secretion in Isolated Pancreatic Cells
COMPARISON WITH THE EFFECTS OF FATTY ACIDS
(Received for publication, August 15, 1996, and in revised form, October 30, 1996)
Sandrine
Gremlich
,
Raphaël
Roduit
and
Bernard
Thorens
From the Institute of Pharmacology and Toxicology, University of
Lausanne, 27 Rue du Bugnon, 1005 Lausanne, Switzerland
GLUT2 expression is strongly decreased in
glucose-unresponsive pancreatic cells of diabetic rodents. This
decreased expression is due to circulating factors distinct from
insulin or glucose. Here we evaluated the effect of palmitic acid and
the synthetic glucocorticoid dexamethasone on GLUT2 expression by
in vitro cultured rat pancreatic islets. Palmitic acid
induced a 40% decrease in GLUT2 mRNA levels with, however, no
consistent effect on protein expression. Dexamethasone, in contrast,
had no effect on GLUT2 mRNA, but decreased GLUT2 protein by about
65%. The effect of dexamethasone was more pronounced at high glucose
concentrations and was inhibited by the glucocorticoid antagonist
RU-486. Biosynthetic labeling experiments revealed that GLUT2
translation rate was only minimally affected by dexamethasone, but that
its half-life was decreased by 50%, indicating that glucocorticoids
activated a posttranslational degradation mechanism. This degradation
mechanism was not affecting all membrane proteins, since the subunit of the Na+/K+-ATPase was unaffected.
Glucose-induced insulin secretion was strongly decreased by treatment
with palmitic acid and/or dexamethasone. The insulin content was
decreased (~55 percent) in the presence of palmitic acid, but
increased (~180%) in the presence of dexamethasone. We conclude that
a combination of elevated fatty acids and glucocorticoids can induce
two common features observed in diabetic cells, decreased GLUT2
expression, and loss of glucose-induced insulin secretion.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Koizumi and T. Yada
Sub-chronic stimulation of glucocorticoid receptor impairs and mineralocorticoid receptor protects cytosolic Ca2+ responses to glucose in pancreatic {beta}-cells
J. Endocrinol.,
May 1, 2008;
197(2):
221 - 229.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Gartner, G. Vila, T. Daneva, A. Nabokikh, F. Koc-Saral, A. Ilhan, O. Majdic, A. Luger, and L. Wagner
New functional aspects of the neuroendocrine marker secretagogin based on the characterization of its rat homolog
Am J Physiol Endocrinol Metab,
July 1, 2007;
293(1):
E347 - E354.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Ranta, D. Avram, S. Berchtold, M. Dufer, G. Drews, F. Lang, and S. Ullrich
Dexamethasone induces cell death in insulin-secreting cells, an effect reversed by exendin-4.
Diabetes,
May 1, 2006;
55(5):
1380 - 1390.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Oberkofler, K. Klein, T. K. Felder, F. Krempler, and W. Patsch
Role of Peroxisome Proliferator-Activated Receptor-{gamma} Coactivator-1{alpha} in the Transcriptional Regulation of the Human Uncoupling Protein 2 Gene in INS-1E Cells
Endocrinology,
February 1, 2006;
147(2):
966 - 976.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. B. Jacobson, T. W. von Geldern, L. Ohman, M. Osterland, J. Wang, B. Zinker, D. Wilcox, P. T. Nguyen, A. Mika, S. Fung, et al.
Hepatic Glucocorticoid Receptor Antagonism Is Sufficient to Reduce Elevated Hepatic Glucose Output and Improve Glucose Control in Animal Models of Type 2 Diabetes
J. Pharmacol. Exp. Ther.,
July 1, 2005;
314(1):
191 - 200.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Ullrich, S. Berchtold, F. Ranta, G. Seebohm, G. Henke, A. Lupescu, A. F. Mack, C.-M. Chao, J. Su, R. Nitschke, et al.
Serum- and Glucocorticoid-Inducible Kinase 1 (SGK1) Mediates Glucocorticoid-Induced Inhibition of Insulin Secretion
Diabetes,
April 1, 2005;
54(4):
1090 - 1099.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Stellato
Post-transcriptional and Nongenomic Effects of Glucocorticoids
Proceedings of the ATS,
November 1, 2004;
1(3):
255 - 263.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Gesina, F. Tronche, P. Herrera, B. Duchene, W. Tales, P. Czernichow, and B. Breant
Dissecting the Role of Glucocorticoids on Pancreas Development
Diabetes,
September 1, 2004;
53(9):
2322 - 2329.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Cottet, P. Dupraz, F. Hamburger, W. Dolci, M. Jaquet, and B. Thorens
cFLIP Protein Prevents Tumor Necrosis Factor-{alpha}-Mediated Induction of Caspase-8-Dependent Apoptosis in Insulin-Secreting {beta}Tc-Tet Cells
Diabetes,
June 1, 2002;
51(6):
1805 - 1814.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Blondeau, J. Lesage, P. Czernichow, J. P. Dupouy, and B. Breant
Glucocorticoids impair fetal {beta}-cell development in rats
Am J Physiol Endocrinol Metab,
September 1, 2001;
281(3):
E592 - E599.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Weinhaus, N. V. Bhagroo, T. C. Brelje, and R. L. Sorenson
Dexamethasone Counteracts the Effect of Prolactin on Islet Function: Implications for Islet Regulation in Late Pregnancy
Endocrinology,
April 1, 2000;
141(4):
1384 - 1393.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. S. Guner, P. R. Kiela, H. Xu, J. F. Collins, and F. K. Ghishan
Differential regulation of renal sodium-phosphate transporter by glucocorticoids during rat ontogeny
Am J Physiol Cell Physiol,
November 1, 1999;
277(5):
C884 - C890.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T.E. Adams, H. Sakurai, and B.M. Adams
Effect of Stress-Like Concentrations of Cortisol on Estradiol-Dependent Expression of Gonadotropin-Releasing Hormone Receptor in Orchidectomized Sheep
Biol Reprod,
January 1, 1999;
60(1):
164 - 168.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. Gremlich, C. Bonny, G. Waeber, and B. Thorens
Fatty Acids Decrease IDX-1 Expression in Rat Pancreatic Islets and Reduce GLUT2, Glucokinase, Insulin, and Somatostatin Levels
J. Biol. Chem.,
November 28, 1997;
272(48):
30261 - 30269.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Davani, A. Khan, M. Hult, E. Martensson, S. Okret, S. Efendic, H. Jornvall, and U. C. T. Oppermann
Type 1 11beta -Hydroxysteroid Dehydrogenase Mediates Glucocorticoid Activation and Insulin Release in Pancreatic Islets
J. Biol. Chem.,
November 3, 2000;
275(45):
34841 - 34844.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Thorens, M.-T. Guillam, F. Beermann, R. Burcelin, and M. Jaquet
Transgenic Reexpression of GLUT1 or GLUT2 in Pancreatic beta Cells Rescues GLUT2-null Mice from Early Death and Restores Normal Glucose-stimulated Insulin Secretion
J. Biol. Chem.,
July 28, 2000;
275(31):
23751 - 23758.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Dupraz, S. Cottet, F. Hamburger, W. Dolci, E. Felley-Bosco, and B. Thorens
Dominant Negative MyD88 Proteins Inhibit Interleukin-1beta /Interferon-gamma -mediated Induction of Nuclear Factor kappa B-dependent Nitrite Production and Apoptosis in beta Cells
J. Biol. Chem.,
November 22, 2000;
275(48):
37672 - 37678.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Cottet, P. Dupraz, F. Hamburger, W. Dolci, M. Jaquet, and B. Thorens
SOCS-1 Protein Prevents Janus Kinase/STAT-dependent Inhibition of beta Cell Insulin Gene Transcription and Secretion in Response to Interferon-gamma
J. Biol. Chem.,
July 6, 2001;
276(28):
25862 - 25870.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1997 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|